INS and metabolic dysfunction-associated steatotic liver disease: In the present years, NAFLD has also been recognized as metabolic-associated fatty liver disease (MAFLD) due to the presence of various metabolic disorders in patients, including disturbances in lipid, glucose, and insulin metabolism.